Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?



To: Biomaven who wrote (30836)4/3/2009 9:21:16 PM
From: tom popeRespond to of 40263
 
I generally believe it's a lot easier to make money in biotech with stocks that few people are talking about rather than ones with active and vociferous followers and detractors

Quite right. Which is why my portfolio is heavily into sleepers such as XOMA, COR, ACAD, AND HGSI. Nobody talks about them any more.


Copyright © 1995-2013 Knight Sac Media. All rights reserved.